Primary omental Gastrointestinal stromal tumor (GIST)

被引：24

作者：

Todoroki T. ^{[1
]}

Sano T. ^{[2
]}

Sakurai S. ^{[2
]}

Segawa A. ^{[2
]}

Saitoh T. ^{[1
]}

Fujikawa K. ^{[1
]}

Yamada S. ^{[1
]}

Hirahara N. ^{[3
]}

Tsushima Y. ^{[4
]}

Motojima R. ^{[1
]}

Motojima T. ^{[1
]}

机构：

[1] Department of Surgery, Motojima General Hospital

[2] Department of Tumor Pathology Gunma University, Maebashi

[3] Department of Gastroenterology, Motojima General Hospital

[4] Department of Diagnostic Radiology and Nuclear Medicine, Gunma University, Maebashi

来源：

World Journal of Surgical Oncology | / 5卷 / 1期

关键词：

Imatinib; Liposarcoma; Imatinib Therapy; Gastroepiploic Artery; Spindle Cell Tumor;

D O I：

10.1186/1477-7819-5-66

中图分类号：

学科分类号：

摘要：

Background: We report herein a rare case of primary omental gastrointestinal stromal tumor (GIST). Case presentation: A 65 year-oldman was referred to our hospital with a huge abdominal mass occupying the entire left upper abdomen as shown by sonography. On computed tomography (CT), this appeared as a heterogeneous low-density mass with faint enhancement. Abdominal angiography revealed that the right gastroepiploic artery supplied the tumor. With such an indication of gastric GIST, liposarcoma, leiomyosarcoma or mesothelioma laparotomy was performed and revealed that this large mass measured 20 × 17 × 6 cm, arising from the greater omentum. It was completely resected. Histopathologically, it was composed of proliferating spindle and epithelioid cells with an interlacing bundle pattern. Immunohistochemically, the tumor was positive for myeloid stem cell antigen (CD34), weakly positive for c-KIT (CD117) and slightly positive for neuron-specific enolase (NSE), but negative for cytokeratin (CK), alpha-smooth muscle actin (SMA) and S-100 protein. A mutation was identified in the platelet-derived growth factor alpha (PDGFRA) juxtamembrane domain (exon 12, codon561) and the tumor was diagnosed as an omental GIST. The postoperative course was uneventful. The patient is treated by Glevec® and is alive well with no sign of relapse. Conclusion: Our case demonstrated a weak immunohistochemical expression of c-kit (CD117) and a point mutation in PDGFRA exon 12 resulting in an Asp for Val561 substitution. Imatinib therapy as an adjuvant to complete resection has been carried out safely. Because of the rarity of primary omental GISTs, it is inevitable to analyze accumulating data from case reports for a better and more detailed understanding of primary omental GISTs. © 2007 Todoroki et al; licensee BioMed Central Ltd.

引用

共 20 条

[1]

Miettinen M., Lasota J., Gastrointestinal stromal tumors (GISTs): Definition, occurrence, pathology, differential diagnosis and molecular genetics, Pol J Pathol, 54, 1, pp. 3-24, (2003)

[2]

Reith J.D., Goldblum J.R., Lyles R.H., Weiss S.W., Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome, Mod Pathol, 13, 5, pp. 577-585, (2000)

[3]

Kindblom L.G., Remotti H.E., Aldenborg F., Meis-Kindblom J.M., Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal, Am J Pathol, 152, 5, pp. 1259-1269, (1998)

[4]

Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M., Muhammad T.G., Matsuzawa Y., Kanakura Y., Shinomura Y., Kitamura Y., Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors, Science, 279, 5350, pp. 577-580, (1998)

[5]

Medeiros F., Corless C.L., Duensing A., Hornick J.L., Oliveira A.M., Heinrich M.C., Fletcher J.A., Fletcher C.D., KIT-negative gastrointestinal stromal tumors: Proof of concept and therapeutic implications, Am J Surg Pathol, 28, pp. 889-894, (2004)

[6]

Sakurai S., Hishima T., Takazawa Y., Sano T., Nakajima T., Saito K., Morinaga S., Fukayama M., Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum, Pathol Int, 51, pp. 524-531, (2001)

[7]

Hirota S., Ohashi A., Nishida T., Isozaki K., Kinoshita K., Shinomura Y., Kitamura Y., Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors, Gastroenterology, 125, pp. 660-667, (2003)

[8]

Sakurai S., Hasegawa T., Sakuma Y., Takazawa Y., Motegi A., Nakajima T., Saito K., Fukayama M., Shimoda T., Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: A subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene, Hum Pathol, 35, 10, pp. 1223-1230, (2004)

[9]

Yamamoto H., Oda Y., Kawaguchi K., Nakamura N., Takahira T., Tamiya S., Saito T., Oshiro Y., Ohta M., Yao T., Tsuneyoshi M., c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue), Am J Surg Pathol, 28, 4, pp. 479-488, (2004)

[10]

Miettinen M., Lasota J., Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis, Arch Pathol Lab Med, 130, 10, pp. 1466-1478, (2006)

← 1 2 →